Short-acting benzodiazepines
    7.
    发明授权
    Short-acting benzodiazepines 有权
    短效苯二氮卓类

    公开(公告)号:US07528127B2

    公开(公告)日:2009-05-05

    申请号:US11650636

    申请日:2007-01-05

    摘要: It has now been found that compounds of the present invention as described in Benzodiazepine derivatives of Formula (I) containing a carboxylic ester moiety and thereby capable of being inactivated by nonspecific tissue esterases in an organ-independent elimination mechanism and thereby providing a more predictable and reproducible pharmacodynamic profile. The compounds of the present invention are suitable for therapeutic purposes, including sedative-hypnotic, anxiolytic, muscle relaxant and anticonvulsant purposes and are useful to be administered intravenously in the following clinical settings: preoperative sedation, anxiolysis, and amnestic use for perioperative events; conscious sedation during short diagnostic, operative or endoscopic procedures; as a component for the induction and maintenance of general anesthesia, prior and/or concomitant to the administration of other anesthetic agents; ICU sedation.

    摘要翻译: 现在已经发现,如在含有羧酸酯部分的式(I)的苯并二氮杂衍生物中所述的本发明化合物,由此能够在器官非依赖性消除机制中被非特异性组织酯酶灭活,从而提供更可预测和 可重现的药效学特征。 本发明的化合物适用于治疗目的,包括镇静催眠,抗焦虑药,肌肉松弛剂和抗惊厥药物,并可用于在以下临床环境中静脉内施用:术前镇静,抗焦虑和围手术期的遗忘用途; 短期诊断,手术或内窥镜手术中有意义的镇静; 作为全身麻醉的诱导和维持的组成部分,先前和/或伴随其他麻醉剂的施用; ICU镇静。